tirzepatide and cardiovascular outcomes An Observational Study of of vs Glucagon-Like Peptide-1 Receptor Agonists 💉 In a large real-world

Providers can also offer practical advice to help patients adapt to their medication

Contraindications Do Not Use If You Have uncontrolled hypertension Have known cardiovascular disease Have a history of hypersensitivity to bremelanotide or any component of the formulation Are pregnant or planning to become pregnant Warnings and Precautions Transient increase in blood pressure and decrease in heart rate: Bremelanotide causes a transient increase in blood pressure (average of 1.9/1.7 mmHg systolic/diastolic, with larger increases in some patients) and a decrease in heart rate following administration

Julie-Ann Lloyd, Amin Andalib, Alice Race, Holly Ann Burt, Farah Husain, Matthew Goldblatt, Matthew Kroh Surgical Endoscopy.2023

The only way to get pharmaceutical-grade retatrutide is through a clinical trial